WHOOP has raised $575 million in Series G funding at a $10.1 billion valuation, led by Collaborative Fund with participation from 2PointZero Group, Qatar Investment Authority, Mubadala Investment Company, Abbott, Mayo Clinic, Macquarie Capital, and others. Individual investors include Cristiano Ronaldo, LeBron James, Rory McIlroy, and Virgil van Dijk.
The raise comes during a period of significant momentum for the company: WHOOP now has over 2.5 million members globally, grew bookings 103% year-over-year in 2025, exited the year at a $1.1 billion run rate, and operated cash flow positive. The company is hiring for over 600 roles globally this year.
The strategic investor that matters most for women’s health: Abbott, the global healthcare company spanning diagnostics, medical devices, and nutrition, has joined as a strategic investor. That relationship could accelerate WHOOP’s push into clinical-grade health monitoring – including the Women’s Health Specialized Blood Biomarker Panel the company announced earlier this month, which adds 11 female-specific biomarkers covering cycle regulation, perimenopause, thyroid function, and bone-metabolic health.
WHOOP’s investment in women’s health has been one of its most notable strategic moves of the past year. Women represent the fastest-growing segment of new members (150% year-over-year growth), female members engage with WHOOP AI 30% more than male members. The new funding will support continued U.S. growth and international expansion across Europe, the GCC, Latin America, and Asia.
“Our raise brings together the world’s most sophisticated investors, leading health institutions, and iconic global athletes behind the mission to unlock human performance and healthspan,” said founder and CEO Will Ahmed. “We are building the personal health platform that people use to improve their health and livelihood.”
